Somatic mutations in pituitary tumors
M. Theodoropoulou
Germany
Pituitary transcription factors, where are we?
S. Camper
USA
Growth hormone receptor antagonists, from discovery to recent use
J. Kopchikh
USA
Hypogonadotrophic hypogonadism
N. Pitteloud
Switzerland
Aberrant hormone receptors in pituitary tumors
P. Kamenicky
France
Dopamine agonists should not be the first line treatment of prolactinomas
N. Biermasz vs. P. Nomikos
The Netherlands / Greece
Surgery or conservative management for pituitary apoplexy
P. Chanson vs. W. Van Furth
France / The Netherlands